These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6173281)

  • 21. [Inhibitors of thrombocytic function for prophylaxis of coronary heart disease (author's transl)].
    Loew D; Breddin K; Uberla K
    MMW Munch Med Wochenschr; 1982 Jan; 124(1):46-56. PubMed ID: 6120454
    [No Abstract]   [Full Text] [Related]  

  • 22. The thrombogenicity of Dacron arterial grafts and its modification by platelet inhibitory drugs.
    Kester RC
    Ann R Coll Surg Engl; 1984 Jul; 66(4):241-6. PubMed ID: 6234841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Secondary prevention following myocardial infarct. Platelet aggregation inhibitors, beta receptor blockers, antiarrhythmics].
    Schröder R
    Dtsch Med Wochenschr; 1981 Apr; 106(17):546-53. PubMed ID: 6111439
    [No Abstract]   [Full Text] [Related]  

  • 24. Platelet inhibition in the management of thrombosis.
    Didisheim P; Kazmier FJ; Fuster V
    Thromb Diath Haemorrh; 1974 Sep; 32(1):21-34. PubMed ID: 4616423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease.
    Genton E
    Circulation; 1980 Dec; 62(6 Pt 2):V111-21. PubMed ID: 6108166
    [No Abstract]   [Full Text] [Related]  

  • 26. [Is modern anti-aggregation therapy effective?].
    Hladovec J
    Cas Lek Cesk; 1984 May; 123(21):630-5. PubMed ID: 6744376
    [No Abstract]   [Full Text] [Related]  

  • 27. [Role of platelet anti-aggregants in cardiovascular surgery].
    Limet R
    Rev Med Liege; 1987 May; 42(10):493-5. PubMed ID: 3497419
    [No Abstract]   [Full Text] [Related]  

  • 28. Present status of antiaggregating agents in coronary and cerebrovascular disease prevention.
    Polli EE; Cortellaro M
    Haematologica; 1980 Jun; 65(3):361-9. PubMed ID: 6778788
    [No Abstract]   [Full Text] [Related]  

  • 29. [Platelet aggregation inhibitors].
    Castaigne A; Benghozi R; Bienvenu MP
    Rev Infirm; 1981 Dec; 31(19):45-8. PubMed ID: 6977177
    [No Abstract]   [Full Text] [Related]  

  • 30. [Current clinical results of antiplatelet medication].
    Ordinas A
    Sangre (Barc); 1984; 29(4-C):833-40. PubMed ID: 6393391
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
    Sherry S
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():173-210. PubMed ID: 6216782
    [No Abstract]   [Full Text] [Related]  

  • 32. Antiplatelet agents: rationale and results.
    Kelton JG
    Clin Haematol; 1983 Feb; 12(1):311-54. PubMed ID: 6132693
    [No Abstract]   [Full Text] [Related]  

  • 33. [Conservative therapy of stroke from an internist's viewpoint].
    Held K
    Wien Med Wochenschr; 1983 May; 133(9):231-3. PubMed ID: 6868622
    [No Abstract]   [Full Text] [Related]  

  • 34. Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
    Harker LA; Hirsh J; Gent M; Genton E
    Prog Hematol; 1975; 9():229-54. PubMed ID: 766074
    [No Abstract]   [Full Text] [Related]  

  • 35. [Anti-aggregation therapy of patients with ischemic heart disease].
    Liusov VA; Savenkov MP
    Ter Arkh; 1988; 60(8):55-9. PubMed ID: 3227479
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevention of stroke.
    Barnett HJ
    Int Anesthesiol Clin; 1984; 22(3):11-29. PubMed ID: 6384054
    [No Abstract]   [Full Text] [Related]  

  • 37. Antiplatelet therapy.
    Sloan RW
    Am Fam Physician; 1981 Oct; 24(4):129-34. PubMed ID: 7025599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet inhibitors in the treatment of thrombosis.
    Hirsh J
    Clin Invest Med; 1978; 1(3-4):191-206. PubMed ID: 391458
    [No Abstract]   [Full Text] [Related]  

  • 39. Sex difference in circulating platelet aggregates and response to antiplatelet treatment.
    Nenci GG; Agnelli G; Parise P; Merante F; Ballatori E
    Thromb Haemost; 1982 Dec; 48(3):341. PubMed ID: 7164022
    [No Abstract]   [Full Text] [Related]  

  • 40. Aspirin and other platelet-aggregation inhibiting drugs.
    Gallus AS
    Med J Aust; 1985 Jan; 142(1):41-7. PubMed ID: 3880861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.